NASDAQ
Cyclo Therapeutics, Inc. (CYTH) has a free cash flow growth of -212.89% as of Friday, May 29, 2026. This represents a 2876.10% decrease compared to its 12-month average of -7.15%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.